Long-acting reversible contraceptives (LARCs) provide a very effective method of contraception, and they do not require ongoing effort on the part of the women. This update of the recent literature outlines the benefits, as well as any potential management considerations, associated with the use of the LARCs currently available in New Zealand. In addition, the use of LARCs in specific patient populations is briefly reviewed. This publication has been commissioned by Bayer. The production of the content is entirely independent but has been reviewed by Bayer for technical accuracy prior to publication.
Please login below to download this issue (PDF)